PERINATAL ISSUES / NEONATAL & PEDIATRIC TRANSFUSION PRACTICE Flashcards
Which of the ff is the most common cause of HDFN?
A. Anti-D
B. ABO incompatibility
C. Anti-K
D. Anti-Fya
~~~
B. ABO incompatibility
This is the #1 cause since prophylactic RhIG use is widespread to prevent D senstization
This condition occurs when there is an increase in hematopoietic drive in fetal development caused by hemolysis due to maternal IgG crossing the placenta. A. Erythroblastosis fetalis B. Hydrops fetalis C. Kernicterus D. Jaundice
A. Erythroblastosis fetalis
This condition occurs when there is liver enlargement of the fetus, leading to decreased plasma osmotic pressure, edema, ascites and effusion due to hemolysis in fetal circulation. A. Erythroblastosis fetalis B. Hydrops fetalis C. Kernicterus D. Jaundice
B. Hydrops fetalis
A condition where there is an increase in unconjugated bilirubin in newborns causing permanent brain damage. A. Erythroblastosis fetalis B. Hydrops fetalis C. Kernicterus D. Jaundice
C. Kernicterus
Which of the ff ethnicity-blood group is most likely affected by ABO HDFN?
A. Group O mom of European ancestry, group B infant
B. Group O mom of Asian ancestry, group A infant
C. Group O mom of African ancestry, group A infant
D. Group O mom of African ancestry, group O infant
B. Group O mom of Asian ancestry, group A infant
Euro and Asian mom Group O, Group A baby
African mom group O, Group B baby
These are more likely to be affected
At what titer is anti-D considered to be critical in a sensitized pregnancy? A. 2 B. 4 C. 8 D. 16
D. 16
At what titer is anti-K considered to be critical in a sensitized pregnancy? A. 2 B. 4 C. 8 D. 16
C. 8
What is the best treatment for a newborn with HDFN who is unresponsive to initial treatments for severe jaundice? A. Phototherapy B. IVIG C. Exchange transfusion D. IUT
C. Exchange transfusion
choices A and B are usually the first treatment of choice, but if newborn becomes unresponsive to these, exchange transfusion is recommended unless infant already received IUT
Which of the ff is NOT a suitable candidate for RhIG administration?
A. A neg female, with anti-G, but no Anti-D
B. O neg female, with weak D RHD genotype other than weak D type 1,2,3
C. O neg female with D pos infant, has allo anti-D
D. A neg female who underwent CVS, has no anti-D
C. O neg female with D pos infant, has allo anti-D
Which antibody to human platelet antigen is the most common cause of fetal and neonatal immune thrombocytopenia (FNAIT)? A. Anti - HPA-1a B. Anti - HPA-5b C. Anti - HPA-1b D. Anti - HPA-4b
A. Anti - HPA-1a = 98% of cases?
B = 10% C = 4% D = more implicated in Asian ancestry
True / false - similar to HDFN, FNAIT cases develop during the first pregnancy, and affects the second and subsequent pregnancies.
False.
First part is true. But it affects the 1st and subsequent pregnancies
Neonates <4 months have immature kidneys and are unable to excrete out excess potassium and calcium. Which of the ff RBC unit requirements ensures that the unit transfused have the lowest amount of excess potassium delivered to the patient?
A. Anticoagulant additive solution used in collection bag
B. Age of RBCs/ <14 days old RBCs
C. Irradiation
D. CMV negative units
A. Anticoagulant additive solution used in collection bag
AS-1, 3, 5, 7, SAGM units have less K+ than CPDA-1
Irradiation results in K+ leakage from RBCs
Neonates are unable to effectively compensate for hypoxia due to their low levels of intracellular 2,3- DPG. Which of the ff RBC unit requirements ensures that the units transfused is not depleted of 2,3-DPG?
A. Anticoagulant additive solution used in collection bag
B. Age of RBCs/ <14 days old RBCs
C. Irradiation
D. CMV negative units
B. Age of RBCs/ <14 days old RBCs
2,3-DPG rapidly decreases after 1-2 weeks of storage
What is the major indication for transfusion in neonates? A. Low birth weight B. Symptomatic anemia C. Hypoxia D. Premature birth
B. Symptomatic anemia
What is the most common indication for exchange transfusion in neonates? A. Premature birth B. HDFN C. Low birth weight D. Hyperbilirubinemia
D. Hyperbilirubinemia